The pharmacokinetics of salicylate in dairy cattle are not altered by simultaneous intravenous ceftiofur sodium and DL-lysine-acetyl salicylate (Aspirin)

Journal of Veterinary Pharmacology and Therapeutics

Volumn 19, Issue 2, 1996, Pages 104-108

  Whittem, T ^a   Freeman, D A ^a   Parton, K ^a   Hanlon, D W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CEFTIOFUR; LYSINE ACETYLSALICYLATE; SALICYLIC ACID; UNCLASSIFIED DRUG; VETALGENE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CATTLE; COMPARTMENT MODEL; CONTROLLED STUDY; DAIRY INDUSTRY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MEAN RESIDENCE TIME; NONHUMAN; PRIORITY JOURNAL;

EID: 0029943636     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.1996.tb00020.x     Document Type: Article

References (22)

1. Anon (1990) Bioequivalence guideline. Center for Veterinary Medicine, Food and Drug Administration, Washington DC.
2. Anon (1991) Naxcel brand of ceftiofur sodium sterile powder. In Manufacturer's product information, The Upjohn Company, Kalamazoo.
3. Anon (1994) Vetalgine acetyl salicylate sterile injection. Manufacturer's product information, TechVet Laboratories. Auckland.
4. Brown, S. A., Jaglan, P. S., & Banting, A. (1991) Ceftiofur sodium: disposition, protein‐binding, metabolism, and residue depletion profile in various species. (Abstract mo. O. A2b). Proceedings of the Fifth Congress of the European Association for Veterinary Pharmacology and Toxicology, Eds Friis C., Gyrd‐Hansen N., Nielsen P., Rasmussen F., Acta Veterinaria Scandinavica (Suppl 87), Fredericksberg, Denmark, pp. 97–99.
5. Clarke, C. R., Burrows, G. E. & Ames, T. R. (1991) Therapy of bovine bacterial pneumonia. Veterinary Clinics of North America Food Animal Practice, 8, 669–694.
6. Dawson, C. M., Wang, T. W. M., Rainbow, S. J. & Tickner T. R. (1988) A non‐extraction HPLC method for the simultaneous determination of serum paracetamol and salicylate. Annals of Clinical Biochemistry, 25, 661–667.
7. Gibaldi, M. & Perrier, D. (1982) Pharmacokinetics, 2nd edn., pp. 1–43, Marcel Dekker Inc, New York.
8. Gingerich, D. A., Baggot, J. D. & Yeary, R. A. (1975) Pharmacokinetics and dosage of aspirin in cattle. Journal of the American Veterinary Medical Association, 167, 945–948.
9. Insel, P. A. (1992) Analgesic‐antipyretics and anti‐inflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th edn. Eds Gilman, A. G., Rall, T. W., Nies, A. S. & Taylor, P., pp. 638–681. McGraw‐Hill, New York.
10. Jaglan, P. S., Yein, F. S., Hornish, R. E., Cox, B. L., Arnold, T. S., Roof, R. D. & Gilbertson, T. J. (1992) Depletion of intramuscularly injected ceftiofur from the milk of dairy cattle. Journal of Dairy Science, 75, 1870–1876.
11. Lees, P. & Higgins, A. J. (1984) Flunixin inhibits prostaglandin production in equine inflammation. Research in Veterinary Science, 37, 347–349.
12. Lees, P. & Higgins, A. J. (1985) Clinical pharmacology and therapeutic uses of non‐steroidal anti‐inflammatory drugs in the horse. Equine Veterinary Journal, 17, 83–96.
13. Lees, P., May, S. A. & McKellar, Q. A. (1991) Pharmacology and therapeutics of non‐steroidal anti‐inflammatory drugs in the dog and cat: 1 General pharmacology. Journal of Small Animal Practice, 32, 183–193.
14. Morkoç, A. C., Hurley, W. L., Whitmore, H. L. & Gustafsson, B. K. (1993) Bovine acute mastitis: effects of intravenous sodium salicylate on endotoxin‐induced intramammary inflammation. Journal of Dairy Science, 76, 2579–2588.
15. Selman, I. E., Allan, E. M. & Dalgleish, R. G. (1986) The effects of flunixin meglumine and oxytetracycline therapy alone and in combination in calves with experimentally induced pneumonic pasteurellosis. Proceedings of the 14th World Congress on Diseases of Cattle, Eds: Hartigan, P. J. & Monaghan, M. L., pp. 606, University College Dublin, Dublin, Ireland.
16. Selman, I. E., Allan, E. M., Gibbs, H. A., Wiseman, A. & Young, W. B. (1984) Effect of antiprostaglandin therapy in experimental parain‐fluenza type 3 pneumonia in weaned. conventional calves. Veterinary Record, 115, 101–105.
17. Soback S., Ziv, G., Winkler, M. & Saran, A. (1989) Pharmacokinetics of ceftiofur administered intravenously and intramuscularly to lactating cows. Israel Journal of Veterinary Medicine, 45, 118–123.
18. Sweeney, C. R. & Smith, J. A. (1990) Diseases of the respiratory system. In Large Animal Internal Medicine. Ed Smith, B. P. pp. 489–619. C. V. Mosby Company, Philadelphia.
19. Weiner, I. M. (1992) Inhibitors of tubular transport of organic acids. In Goodman and Gillman's the Pharmacological Basis of Therapeutics. 8th edn, Eds Gilman, A. G., Rall, T. W., Nies, A. S., & Taylor, P. pp. 743–748. McGraw‐Hill, New York.
20. Westlake, W. J. (1988) Bioavailability and bioequivalence of pharmaceutical formulations. In Biopharmaceutical Statistics for Drug Development. Ed Peace, K. E. pp. 329–352. Marcel Dekker Inc. New York.
21. Whittem, T., Freeman, D. A., Hanlon, D. & Parton, K. (1995) The effects on the pharmacokinetics of intravenous ceftiofur sodium in dairy cattle of simultaneous intravenous acetyl salicylate (aspirin) or probenecid. Journal of Veterinary Pharmacology and Therapeutics, 18, 61–67.
22. Yamaoka, K., Nakagawa, T., & Uno, T. (1978) Application of Akaike's Information Criterion (AIC) in the evaluation of linear pharmacoki‐netic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165–175.